Form 4: Tourmaline Bio Officer Donates Shares

Kevin Bruce Johnson, Chief Regulatory Officer of Tourmaline Bio, Inc., donated 6,250 shares of common stock to a donor-advised fund.

Summary

• Kevin Bruce Johnson, Chief Regulatory Officer of Tourmaline Bio, Inc. (TRML), reported a change in beneficial ownership.
• On October 15, 2025, Mr. Johnson disposed of 6,250 shares of common stock.
• This disposition was a gift (Transaction Code G) to a donor-advised fund for charitable purposes, with a transaction price of $0 per share.
• Following this transaction, Mr. Johnson beneficially owns 51,584 shares of Tourmaline Bio, Inc. common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a charitable donation, which is generally neutral for the company's stock performance but positive in terms of corporate social responsibility.

Positives

• The disposition of shares was for charitable purposes, benefiting a donor-advised fund.

Negatives

• The Chief Regulatory Officer disposed of 6,250 shares of common stock, which, while a gift, represents a reduction in insider ownership.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Minimal impact; a small reduction in insider ownership through a charitable gift, not a market sale.
• Charitable Organizations: Positive impact from receiving the gifted shares.

Key Dates

Recommendation

The filing reports a routine insider transaction involving a charitable donation of shares by a Chief Regulatory Officer. This type of transaction is generally not considered a significant indicator for investment decisions and does not reflect on the company's operational or financial performance. Therefore, a 'hold' recommendation is appropriate as this event alone does not provide a basis for altering an existing investment thesis.

Keywords

Tourmaline Bio, TRML, Form 4, insider transaction, share disposition, Kevin Bruce Johnson, Chief Regulatory Officer, stock donation